![Reshema Kemps-Polanco](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 1 M $ au 30/06/2026
Reshema Kemps-Polanco is currently Independent Director at Charles River Laboratories International, Inc. since 2024.
Current roles also include Director positions at Healthcare Businesswomens Association, Healthcare Leadership Council, CEO Roundtable on Cancer, Inc., and Global Advisory Board.
Currently serves as Chief Commercial Officer & Executive Vice President at Novartis Corp.
Former roles include President-Janssen Cardiovascular at Johnson & Johnson from 2014 to 2021 and Executive Vice President at Novartis Oncology, Inc. from 2021 to 2023.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/05/2026 | 4 563 ( 0,01% ) | 1 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Directeur/Membre du Conseil | 22/01/2024 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | - |
Healthcare Leadership Council
 Healthcare Leadership Council Medical/Nursing ServicesHealth Services Provides healthcare services | Directeur/Membre du Conseil | - |
Healthcare Businesswomens Association
 Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Operates women healthcare associations | Directeur/Membre du Conseil | - |
Global Advisory Board | Directeur/Membre du Conseil | - |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01/09/2023 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Charles River Laboratories International, Inc.
 Charles River Laboratories International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing and research services on a contract basis | Commercial Services |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Healthcare Businesswomens Association
Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Operates women healthcare associations | Commercial Services |
Healthcare Leadership Council
Healthcare Leadership Council Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
CEO Roundtable on Cancer, Inc.
CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Commercial Services |
Global Advisory Board |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
